Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer
Taha Koray Şahin, Alessandro Rizzo, Deniz Can Güven, Sercan Aksoy
Topics & Concepts
MedicineMetastatic breast cancerOncologyHormone receptorBreast cancerInternal medicineHER2 negativeCancerAdvanced Breast Cancer TherapiesChronic Lymphocytic Leukemia ResearchBreast Cancer Treatment Studies